Morepen Logo

"EDQM awards Certificate of Suitability (CEP) to Morepen for Montelukast Sodium & Atorvastatin Calcium Trihydrate. Morepen already holds CEP for Loratadine"       "Morepen Laboratories scores No.1 position globally for its bulk drug Montelukast"      "Company's efficient operations result in over 25-fold increase in net profit for the FY 2015-16"     

About The Company

Some things will always remain unfettered. Like sunshine and air, like suffering and joy, like sharing and caring. Some things will never recognize the confines of space and time. Like human endeavour and enterprise, like the desire to touch life. At Morepen, we are taking our expertise and experience in Wellness to new countries and new people with an increasing focus on global exports. And in doing so, our spirit of caring is crossing boundaries.

Read more

Active Pharmaceutical Ingredient

Morepen started its bulk drug business in 1985 with the manufacturing of Ampicillin, Amoxicillin...

Read more

Formulations

Since our inception in 1995, the Medicus division has been catering to the needs of the common man...

Read more

HomeHealth

Recognizing the requirement of innovative and technologically advanced ...

Read more

Dr. Morepen

Keeping in line with Morepen's commitment to healthier future for all, The company has taken...

Read more

Grooming

Dr. Morepen, now introduces in India, GUBB USA. GUBB international grooming range is specially designed to recharge you & brighten you..

Read more

Wellness

Dr. Morepen NOW is a Heart Health Centre, with a 360 ° approach towards the treatment of heart patients & people with related diseases like diabetes, high blood pressure, cholesterol and obesity. Here, your heart fitness is their top priority...

Read more

Recent News

August - 22 - 2018
Annual Report 2017-2018 new

August - 21 - 2018
For Notice of 33rd AGM dt 21.09.2018 new

August - 13 - 2018
Press Release 13.08.2018 new

August - 13 - 2018
Investor Presentation new

August - 13 - 2018
Un-audited Financial Results For the Quarter ended 30th June, 2018

July - 30 - 2018
Press Release - Twin USFDA approvals for Morepen Labs’ Bulk Drugs (API) facilities

July - 26 - 2018
Notice of Rescheduling of Board Meeting and closure of Trading window

July - 24 - 2018
Notice of Board Meeting & Closure of Trading Window

May - 16 - 2018
Intimation of Conference Call

May - 16 - 2018
Investor Presentation

May - 16 - 2018
Press Release 16.05.2018

May - 16 - 2018
Audited Financial Results For the Quarter and Financial Year ended 31st March, 2018

 

May - 09 - 2018
Notice of Board Meeting & Closure of Trading Window

 

March - 09 - 2018
Women's Day Celebrations at Morepen Labs on 8 March 2018

 

January - 22 - 2018
Intimation of Conference Call

 

January - 22 - 2018
Morepen Investor Presentation Jan 2018 22nd Jan

 

January - 22 - 2018
Morepen Press Release

 

January - 22 - 2018
Un-audited Financial Results For the Quarter ended 31st December, 2017

 

January - 17 - 2018
Morepen Article in Business India - Finally in good health

 

January -12 - 2018
Notice of Board Meeting & Closure of Trading Window.

 

November - 10 - 2017
Press Release

 

November - 10 - 2017
Un-audited Financial Results for the Quarter ended 30th September, 2017

 

September - 22 - 2017
Proceeding/Outcome of 32nd AGM held on 22.09.2017

 

September - 22 - 2017
Voting Results of 32nd AGM held on 22.09.2017

 

 


View all news